TherapeuticsMD | TXMD - Selling And Administration Expenses


TherapeuticsMD reported $1.23M in Selling and Administration Expenses for its fiscal quarter ending in June of 2024.





Selling And Administration Expenses Change Date
AbbVie USD 3.89B 325M Dec/2025
Alterity Therapeutics Limited AUD 2.29M 649.1K Jun/2023
Cipla INR 13.25B 101.8M Dec/2025
Clal Biotechnology ILS 3.31M 513K Dec/2022
Compugen USD 2.33M 50K Sep/2025
CSL USD 1.23B 498M Dec/2025
Grifols EUR 333.1M 157M Sep/2025
Novo Nordisk DKK 2.86B 13.25B Jun/2025
Pfizer USD 4.08B 894M Dec/2025
TherapeuticsMD USD 1.23M 90K Jun/2024